Kohlberg takes victory lap for Partners’ PCI Pharma in $3bn-plus deal

Swiss PE giant Partners Group will retain a minority investment in the pharma services company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this